AuNP-based biosensors for the diagnosis of pathogenic human coronaviruses: COVID-19 pandemic developmentsArticle Published on 2022-10-012022-11-15 Journal: Analytical and bioanalytical chemistry [Category] COVID19(2023년), SARS, 치료기술, [키워드] Accuracy Antigen Asymptomatic carrier AuNP AuNPs biofluid Biomarker CoV COVID-19 epidemic COVID-19 pandemic CoVs CRISPR Diagnosis Diagnostic method Early detection example gold helping higher risk highlight highly pathogenic CoV Human human coronavirus human coronaviruses identify Laboratory MERS-CoV nanobiosensors nucleic acids optical outbreak pathogenic Pathogenic. platform point-of-care Probability Protein provided RT-PCR SARS-CoV-1 SARS-CoV-2 Spread the disease the SARS-CoV-2 Transmission treatment intervention virus viruses [DOI] 10.1007/s00216-022-04193-2 PMC 바로가기
Serological screening in wild ruminants in Germany, 2021/2022: No evidence of SARS-CoV-2, bluetongue virus or pestivirus spread but high seroprevalences against Schmallenberg virusArticle Published on 2022-09-012022-11-15 Journal: Transboundary and emerging diseases [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] acute respiratory syndrome age antibodies antibody betacoronaviruses bluetongue disease bovine viral diarrhoea collected coronavirus COVID-19 deer disease ELISA Germany human SARS-CoV-2 infectious agent investigated no evidence of occurred pandemic pathogenic Pestivirus positive presence of antibody public health RBD risk ruminant ruminants SARS-CoV-1 SARS-CoV-2 scored Serologically serology Spread susceptible tested the RBD the receptor-binding domain the SARS-CoV-2 virus virus Virus neutralisation while wildlife Wildlife. [DOI] 10.1111/tbed.14600 PMC 바로가기
SARS-CoV-2 vaccine-induced antibody and T cell response in SARS-CoV-1 survivorsArticle Published on 2022-08-302022-11-15 Journal: Cell Reports [Category] SARS, 변종, 진단, [키워드] acute respiratory syndrome antibody boost comparable coronavirus disease Coronavirus-2 CP: Immunology cross-reactive elicit healthy individual Immunity immunized induce memory T cells neutralization Neutralizing neutralizing antibody omicron robust SARS-CoV-1 SARS-CoV-1 survivors SARS-CoV-2 SARS-CoV-2 variant serum sample single dose survivor Survivors T cell response T cells the antibody response vaccination Vaccine variants of concern variants of concern. [DOI] 10.1016/j.celrep.2022.111284 PMC 바로가기
IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease SeverityArticle Published on 2022-08-262022-11-15 Journal: The Journal of Infectious Diseases [Category] SARS, 진단, [키워드] acute respiratory syndrome Against anti-S anti-S antibody anti-S2 anti-SARS-CoV-2 antibody Anti-spike antibody Antibody Response bidirectional cohorts common cold common cold human coronaviruses (HCoVs) coronavirus correlated COVID-19 cross-react cross-reactive antibody cross-reactive antibody response decrease disease disease severity domain Effect elicited HKU1 homologous Human human coronavirus IgG IgG antibody immune immune imprinting. Immunoglobulin morbidity and mortality Multiplex assay OC43 Organ failure Protective RaTG13 recognizing response S proteins S1-reactive antibodies SARS-CoV-1 SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection sera serum sample severe coronavirus disease Severity of disease significantly increased SOFA spike strain subject with COVID-19 [DOI] 10.1093/infdis/jiac022 PMC 바로가기
High activity of an affinity-matured ACE2 decoy against Omicron SARS-CoV-2 and pre-emergent coronavirusesOmicron SARS-CoV-2 및 사전 출현 코로나바이러스에 대한 친화성 성숙 ACE2 유인물의 높은 활성Article Published on 2022-08-252022-09-11 Journal: PLoS ONE [Category] SARS, 변종, [키워드] ACE2 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adeno-associated virus affinity airway angiotensin Angiotensin-converting enzyme angiotensin-converting enzyme 2 antigenic antigenic drift binding can not clade complicate coronavirus coronavirus coronavirus disease Coronavirus disease 2019 Coronaviruses COVID-19 COVID-19 pandemic decoy develop drug Efficacy Evolution exceptional genetic diversity human ACE2 inhibitor intranasal intrinsic mitigate monoclonal antibody mutant nanomolar affinity Neutralizing omicron pandemic populations preparation Prophylaxis receptor Receptor-binding domain sarbecovirus sarbecovirus Sarbecoviruses SARS-CoV-1 SARS-CoV-2 SARS-CoV-2 spike protein SARS-CoV-2 variant SARS-CoV-2 variants severe acute respiratory syndrome Coronavirus Spike protein the SARS-CoV-2 the spike protein therapeutic Threats Treatment Vaccine variant variants viral evolution viral genome viral spike viral strain viral strains virus virus widespread zoonotic [DOI] 10.1371/journal.pone.0271359 PMC 바로가기 [Article Type] Article
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses중증 급성 호흡기 증후군 코로나바이러스 2 백신 접종은 계절성 인간 코로나바이러스에 대한 중화 활성을 향상시킵니다Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 치료법, [키워드] 229E activity acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Against analyzed average BNT162b2 causative agent ChAdOx1 ChAdOx1 nCoV-19 circulating colds common cold Concentration coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination COVID-19 vaccinations cross-neutralization cross-protection determined by Efficiency Endemic Gene Expression HCoV HCoV-229E HCoV-NL63 HCoV-OC43 HCoVs Heterologous Huh-7 cells Human human coronavirus incubated individual inhibitory activity MERS MERS-CoV Middle East Middle East respiratory syndrome MOST neutralization neutralize Neutralizing activity NL63 nucleocapsid expression OC43 Preexisting immunity pseudoparticle pseudovirion pseudovirions reporter reporter gene respiratory SARS-CoV-1 SARS-CoV-2 SARS-CoV-2 vaccination seasonal seasonal coronavirus seasonal coronaviruses seasonal coronaviruses. sera severe acute respiratory syndrome Coronavirus significantly increased Spike proteins these viruses vaccination Viral RNA virus [DOI] 10.1093/cid/ciac057 PMC 바로가기 [Article Type] Article
Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity세포 표면 SARS-CoV-2 뉴클레오캡시드 단백질은 선천성 및 후천성 면역을 조절합니다Article Published on 2022-08-052022-09-11 Journal: Science Advances [Category] SARS, 변종, 치료기술, 치료법, 치료제, [키워드] activate adaptive antibody antigenicity bind Cell cell surface cells chemokine chemokines chemotaxis Combination conserved CoVs cross-reactive cytosol detect electrostatic heparan sulfate heparin high affinity high-affinity binding human CoVs immune cells Immunity induce infected cells inhibited Innate immune cells Innate immunity leukocyte leukocytes live cells MERS-CoV modulate neighboring cell neighboring cells nucleocapsid protein Protein released SARS-CoV-1 SARS-CoV-2 SARS-CoV-2 nucleocapsid SARS-CoV-2 variant SARS-CoV-2 variants SARS-CoV-2-infected cell SARS-CoV-2-infected cells sequestering Strains sulfate sulfated T cell T cell responses transfected cell Vaccine zoonotic [DOI] 10.1126/sciadv.abp9770 PMC 바로가기 [Article Type] Article
Broad-spectrum antiviral activity of Spatholobus suberectus Dunn against SARS-CoV-2, SARS-CoV-1, H5N1, and other enveloped virusesArticle Published on 2022-08-012022-11-15 Journal: Phytotherapy research : PTR [Category] SARS, 치료제, [키워드] ACE2 receptor ADA Antiviral antiviral activity antivirals antivirals. approach blocked caused complementary COVID-19 pandemic death drug candidate effective drugs evaluated H5N1 HIV-1 Host indicated inhibited inhibitor inhibitory activity plant pseudotyped pseudovirus responsible Safe SARS-CoV-1 SARS-CoV-1 and 2 SARS-CoV-2 SARS-CoV-2 spike glycoprotein SARS-CoVs Spatholobus suberectus Dunn target cell Toxicity treating COVID-19 Treatment viral entry virus viruses [DOI] 10.1002/ptr.7452 PMC 바로가기
Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast단기 및 장기 면역을 위한 SARS-CoV-2 백신의 효과: 유행병 대비에 대한 일반 개요Review Published on 2022-07-302022-09-11 Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, 치료제, [키워드] ACE2 anchor Anti-spike antibodies bind booster Cell cell receptor Comorbidity concerning Contrast COVID-19 COVID-19 disease COVID-19 pandemic dentistry diagnoses disease disease severity Efficiency enzyme evaluate flu Golgi apparatus Host immunization Infection Interaction knowledge mechanism MERS mortality rate observance pandemic Patient Pfizer Primary prevention produced Protein Protein target protocol provide question reduction in Release released RNA SARS-CoV-1 SARS-CoV-2 SARS-CoV-2 disease SARS-CoV-2 variant SARS-CoV-2 variants severity significant increase spike Spike protein Spike proteins the cells the disease the SARS-CoV-2 Therapies therapy TMPRSS2 Treatment protocol treatment protocols Vaccine Vaccines Vaccines. Viral viral infection virion virus virus viruses [DOI] 10.3390/ijms23158485 PMC 바로가기 [Article Type] Review
All-Atom Simulations of Human ACE2-Spike Protein RBD Complexes for SARS-CoV-2 and Some of its Variants: Nature of Interactions and Free Energy Diagrams for Dissociation of the Protein ComplexesSARS-CoV-2 및 일부 변이체에 대한 인간 ACE2-스파이크 단백질 RBD 복합체의 전체 원자 시뮬레이션: 단백질 복합체의 해리를 위한 상호작용 및 자유 에너지 다이어그램의 특성Article Published on 2022-07-282022-09-11 Journal: The journal of physical chemistry. B [Category] COVID19(2023년), SARS, 변종, [키워드] ACE2 Analysis atomic level average Comparative analysis Diagram dissociation electrostatic electrostatic interaction energy FIVE Free free energy Free energy calculation Free energy calculations Human human Ace2 protein hydrogen Hydrogen bond increase increase in Interaction investigated L452R molecular molecular dynamics mutant N501Y Nature nonspecific pathway positive Protein RBD RBD-ACE2 RBDs Receptor binding domain SARS-CoV-1 SARS-CoV-2 Simulation Spike protein the RBD the spike protein trajectory variant variants variants of SARS-CoV-2 wild type [DOI] 10.1021/acs.jpcb.2c00833 PMC 바로가기 [Article Type] Article